OMNOVA Solutions Inc. OMN said Wednesday that it has entered an agreement to be acquired by U.K. chemical company Synthomer plc for $10.15 per share in cash.
Omnova shares were trading up 55.62% at $9.98 at the time of publication.
"The offer price represents a premium of 52% over OMNOVA's three-month weighted average share price of $6.67,” Omnova CEO Anne Noonan said in a statement.
The transaction is expected to close in late 2019 or early 2020 and has been approved unanimously by the OMNOVA and Synthomer boards. Completion of the transaction is subject to certain customary closing conditions.
Morgan Stanley is acting as exclusive financial advisor to OMNOVA Solutions and Jones Day is acting as its legal counsel.
Related Links:
5 Stocks To Watch For July 3, 2019
As Facebook Prepares To Launch Libra, Regulators Are Watching
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
